At2r PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Critical Role of RAAS in Vasculoprotection: New Science PowerPoint PPT Presentation
Critical Role of RAAS in Vasculoprotection: New Science - Critical Role of RAAS in Vasculoprotection: New Science New aspects of RAAS ACE homologues ACE2 Soluble ACE ACE substrates Ang (1 7) Ang (1 9) N-acetyl-seryl ...
Critical Role of RAAS in Vasculoprotection: New Science New aspects of RAAS ACE homologues ACE2 Soluble ACE ACE substrates Ang (1 7) Ang (1 9) N-acetyl-seryl ...
| PowerPoint PPT presentation | free to view
Critical Role of RAAS in Vasculoprotection: New Science PowerPoint PPT Presentation
Critical Role of RAAS in Vasculoprotection: New Science - Critical Role of RAAS in Vasculoprotection: New Science. New aspects of ... N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) ... Strauss MH, Hall AS. ...
Critical Role of RAAS in Vasculoprotection: New Science. New aspects of ... N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) ... Strauss MH, Hall AS. ...
| PowerPoint PPT presentation | free to view
Viral%20(and%20other)%20techniques%20in%20gene%20therapy%20for%20hypertension PowerPoint PPT Presentation
Viral%20(and%20other)%20techniques%20in%20gene%20therapy%20for%20hypertension - The lentiviruses allow large transgene cassettes to be stably transfected in vivo. Larger cassette sizes allow for incorporation of transcriptional control systems, ...
The lentiviruses allow large transgene cassettes to be stably transfected in vivo. Larger cassette sizes allow for incorporation of transcriptional control systems, ...
| PowerPoint PPT presentation | free to download
Metabolismus myokardu PowerPoint PPT Presentation
Metabolismus myokardu - Title: Patofyziologicky v znamn poruchy metabolismu I Author: avasku Last modified by: prof. MUDr. Anna Va k , CSc Created Date: 1/8/2003 7:10:36 AM
Title: Patofyziologicky v znamn poruchy metabolismu I Author: avasku Last modified by: prof. MUDr. Anna Va k , CSc Created Date: 1/8/2003 7:10:36 AM
| PowerPoint PPT presentation | free to view
Kidney disease in hypertension and diabetes. Diagnosis, treatment. PowerPoint PPT Presentation
Kidney disease in hypertension and diabetes. Diagnosis, treatment. - Title: Kidney disease in hypertension and diabetes. Diagnosis, treatment. Progression of chronic renal disease. Renal disease as a cardiovascular risk factor.
Title: Kidney disease in hypertension and diabetes. Diagnosis, treatment. Progression of chronic renal disease. Renal disease as a cardiovascular risk factor.
| PowerPoint PPT presentation | free to view
Onemocnen PowerPoint PPT Presentation
Onemocnen - Onemocn n ledvin u hypertenze a diabetu. Diagnostika, l ba. Progrese chronick ho onemocn n ledvin. Onemocn n ledvin jako kardiovaskul rn rizikov faktor
Onemocn n ledvin u hypertenze a diabetu. Diagnostika, l ba. Progrese chronick ho onemocn n ledvin. Onemocn n ledvin jako kardiovaskul rn rizikov faktor
| PowerPoint PPT presentation | free to view
Onemocnen PowerPoint PPT Presentation
Onemocnen - Onemocn n ledvin u hypertenze a diabetu. Nefroprotektivn l ba Ludmila Brunerov II. intern klinika FNKV
Onemocn n ledvin u hypertenze a diabetu. Nefroprotektivn l ba Ludmila Brunerov II. intern klinika FNKV
| PowerPoint PPT presentation | free to view
To Gianfranco from Rosanna PowerPoint PPT Presentation
To Gianfranco from Rosanna - To Gianfranco from Rosanna
To Gianfranco from Rosanna
| PowerPoint PPT presentation | free to view
Recent Clinical Trial Results: A Critique PowerPoint PPT Presentation
Recent Clinical Trial Results: A Critique - For equivalent reductions in BP, RAAS blockers provide more target organ ... Alistair S. Hall. Controversies in CV Medicine. Con. Ross T. Tsuyuki. Michael A. McDonald ...
For equivalent reductions in BP, RAAS blockers provide more target organ ... Alistair S. Hall. Controversies in CV Medicine. Con. Ross T. Tsuyuki. Michael A. McDonald ...
| PowerPoint PPT presentation | free to view
Epidemiologia de la IC avanzada PowerPoint PPT Presentation
Epidemiologia de la IC avanzada - Epidemiologia de la IC avanzada! Sobrevida TxC (0.001%)! 1 Cancer 0.8 0.6 IC Avanzada (0.1%) 0.4 0.2 IC Avanzada Insuficiencia Card aca (1-2 %) 0 0 12 24 36 48 60
Epidemiologia de la IC avanzada! Sobrevida TxC (0.001%)! 1 Cancer 0.8 0.6 IC Avanzada (0.1%) 0.4 0.2 IC Avanzada Insuficiencia Card aca (1-2 %) 0 0 12 24 36 48 60
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
at2r — Search results on PowerShow.com